StageZero Life Sciences Ltd. (SZLSF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2022 | -11.41 Million USD | -91.46% |
| 2021 | -7.68 Million USD | -6.96% |
| 2020 | -7.18 Million USD | -66.6% |
| 2019 | -4.31 Million USD | -9.34% |
| 2018 | -3.94 Million USD | -33.81% |
| 2017 | -2.94 Million USD | 50.14% |
| 2016 | -5.91 Million USD | 1.76% |
| 2015 | -6.01 Million USD | 8.98% |
| 2014 | -6.61 Million USD | 25.17% |
| 2013 | -8.83 Million USD | -73.92% |
| 2012 | -5.07 Million USD | -15.73% |
| 2011 | -4.38 Million USD | 8.84% |
| 2010 | -4.81 Million USD | 9.88% |
| 2009 | -5.34 Million USD | 50.64% |
| 2008 | -10.82 Million USD | -11.25% |
| 2007 | -9.72 Million USD | -26.9% |
| 2006 | -7.66 Million USD | -189.53% |
| 2005 | -2.64 Million USD | 43.33% |
| 2004 | -4.67 Million USD | -1667.58% |
| 2003 | -264.35 Thousand USD | 69.55% |
| 2002 | -868.15 Thousand USD | 23.34% |
| 2001 | -1.13 Million USD | -358.97% |
| 2000 | -246.73 Thousand USD | -70.74% |
| 1999 | -144.51 Thousand USD | -2238.48% |
| 1998 | -6179.69 USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -384.62 Thousand USD | 0.0% |
| 2024 Q2 | -649.46 Thousand USD | -68.86% |
| 2023 Q3 | -821.88 Thousand USD | -104.68% |
| 2023 Q1 | -2.19 Million USD | 87.19% |
| 2023 Q2 | -401.53 Thousand USD | 81.72% |
| 2022 Q1 | 1.49 Million USD | 165.24% |
| 2022 Q3 | 1.42 Million USD | 382.98% |
| 2022 Q2 | -505.3 Thousand USD | -133.74% |
| 2022 FY | -14.71 Million USD | -91.46% |
| 2022 Q4 | -17.14 Million USD | -1298.96% |
| 2021 Q1 | -7.29 Million USD | -1586.21% |
| 2021 Q3 | -2.22 Million USD | -151.31% |
| 2021 Q4 | -2.29 Million USD | -3.32% |
| 2021 Q2 | 4.32 Million USD | 159.34% |
| 2021 FY | -7.68 Million USD | -6.96% |
| 2020 Q3 | -4.64 Million USD | -2697.67% |
| 2020 Q4 | 490.94 Thousand USD | 110.57% |
| 2020 FY | -7.18 Million USD | -66.6% |
| 2020 Q1 | -2.69 Million USD | -420.17% |
| 2020 Q2 | 178.81 Thousand USD | 106.62% |
| 2019 FY | -4.31 Million USD | -9.34% |
| 2019 Q1 | -5.97 Million USD | -9243.35% |
| 2019 Q4 | 843.07 Thousand USD | -55.24% |
| 2019 Q3 | 1.88 Million USD | 439.98% |
| 2019 Q2 | -554.01 Thousand USD | 90.73% |
| 2018 Q4 | -63.97 Thousand USD | 90.48% |
| 2018 FY | -3.94 Million USD | -33.81% |
| 2018 Q1 | -578.58 Thousand USD | -49.9% |
| 2018 Q2 | -2.62 Million USD | -354.45% |
| 2018 Q3 | -671.98 Thousand USD | 74.44% |
| 2017 Q1 | -1.5 Million USD | -243.26% |
| 2017 FY | -2.94 Million USD | 50.14% |
| 2017 Q3 | -601.85 Thousand USD | -31.75% |
| 2017 Q4 | -385.98 Thousand USD | 35.87% |
| 2017 Q2 | -456.82 Thousand USD | 69.6% |
| 2016 FY | -5.91 Million USD | 1.76% |
| 2016 Q1 | -2.65 Million USD | -74.7% |
| 2016 Q4 | 1.04 Million USD | 137.93% |
| 2016 Q3 | -2.76 Million USD | -80.21% |
| 2016 Q2 | -1.53 Million USD | 42.31% |
| 2015 Q1 | -957.02 Thousand USD | 45.91% |
| 2015 Q2 | -1.29 Million USD | -35.39% |
| 2015 Q3 | -2.2 Million USD | -70.5% |
| 2015 FY | -6.01 Million USD | 8.98% |
| 2015 Q4 | -1.52 Million USD | 31.08% |
| 2014 FY | -6.61 Million USD | 25.17% |
| 2014 Q4 | -1.76 Million USD | -121.05% |
| 2014 Q3 | -800.41 Thousand USD | 68.48% |
| 2014 Q2 | -2.53 Million USD | -55.87% |
| 2014 Q1 | -1.62 Million USD | 25.85% |
| 2013 FY | -8.83 Million USD | -73.92% |
| 2013 Q4 | -2.19 Million USD | 33.48% |
| 2013 Q3 | -3.3 Million USD | -81.69% |
| 2013 Q2 | -1.81 Million USD | -21.1% |
| 2013 Q1 | -1.5 Million USD | -43.07% |
| 2012 Q2 | -1.25 Million USD | 0.51% |
| 2012 Q4 | -1.04 Million USD | 27.66% |
| 2012 Q1 | -1.26 Million USD | 0.83% |
| 2012 Q3 | -1.45 Million USD | -15.36% |
| 2012 FY | -5.07 Million USD | -15.73% |
| 2011 FY | -4.38 Million USD | 8.84% |
| 2011 Q1 | -1.17 Million USD | -2.35% |
| 2011 Q2 | -1.12 Million USD | 4.4% |
| 2011 Q3 | -3.45 Million USD | -207.17% |
| 2011 Q4 | -1.27 Million USD | 63.15% |
| 2010 Q3 | -1.01 Million USD | 16.82% |
| 2010 Q4 | -1.15 Million USD | -12.85% |
| 2010 Q2 | -1.22 Million USD | 13.1% |
| 2010 Q1 | -1.41 Million USD | -159.83% |
| 2010 FY | -4.81 Million USD | 9.88% |
| 2009 Q4 | -542.72 Thousand USD | 58.72% |
| 2009 Q2 | -1.51 Million USD | 3.04% |
| 2009 Q1 | -1.55 Million USD | -71.99% |
| 2009 Q3 | -1.31 Million USD | 13.04% |
| 2009 FY | -5.34 Million USD | 50.64% |
| 2008 Q4 | -906.77 Thousand USD | 75.49% |
| 2008 Q1 | -2.51 Million USD | 56.12% |
| 2008 Q2 | -3.92 Million USD | -56.2% |
| 2008 Q3 | -3.69 Million USD | 5.75% |
| 2008 FY | -10.82 Million USD | -11.25% |
| 2007 FY | -9.72 Million USD | -26.9% |
| 2007 Q1 | -1.44 Million USD | 30.89% |
| 2007 Q2 | -1.66 Million USD | -14.76% |
| 2007 Q3 | -2.31 Million USD | -39.43% |
| 2007 Q4 | -5.72 Million USD | -147.04% |
| 2006 Q4 | -2.09 Million USD | -10.78% |
| 2006 Q3 | -1.89 Million USD | -10.84% |
| 2006 Q2 | -1.7 Million USD | 9.7% |
| 2006 Q1 | -1.89 Million USD | -1005.43% |
| 2006 FY | -7.66 Million USD | -189.53% |
| 2005 Q2 | -597.16 Thousand USD | 35.88% |
| 2005 Q3 | -1.25 Million USD | -110.73% |
| 2005 FY | -2.64 Million USD | 43.33% |
| 2005 Q4 | 208.81 Thousand USD | 116.59% |
| 2005 Q1 | -931.3 Thousand USD | -68.28% |
| 2004 FY | -4.67 Million USD | -1667.58% |
| 2004 Q2 | -1.46 Million USD | -34.3% |
| 2004 Q4 | -553.43 Thousand USD | 61.71% |
| 2004 Q1 | -1.08 Million USD | -1332.89% |
| 2004 Q3 | -1.44 Million USD | 1.02% |
| 2003 Q2 | -436.45 Thousand USD | -162.43% |
| 2003 Q3 | -512.56 Thousand USD | -17.44% |
| 2003 Q4 | -75.87 Thousand USD | 85.2% |
| 2003 Q1 | 699.09 Thousand USD | 325.87% |
| 2003 FY | -264.35 Thousand USD | 69.55% |
| 2002 FY | -868.15 Thousand USD | 23.34% |
| 2002 Q4 | -309.5 Thousand USD | 37.61% |
| 2002 Q1 | -478.05 Thousand USD | -54.84% |
| 2002 Q2 | -394.34 Thousand USD | 17.51% |
| 2002 Q3 | -496.09 Thousand USD | -25.8% |
| 2001 Q1 | -410.24 Thousand USD | -71.49% |
| 2001 FY | -1.13 Million USD | -358.97% |
| 2001 Q4 | -308.74 Thousand USD | -60.0% |
| 2001 Q3 | -192.97 Thousand USD | 31.12% |
| 2001 Q2 | -280.16 Thousand USD | 31.71% |
| 2000 Q4 | -239.22 Thousand USD | -12.97% |
| 2000 Q3 | -211.75 Thousand USD | 0.0% |
| 2000 Q1 | -7770.18 USD | 93.79% |
| 2000 FY | -246.73 Thousand USD | -70.74% |
| 1999 FY | -144.51 Thousand USD | -2238.48% |
| 1999 Q4 | -125.21 Thousand USD | -2953.89% |
| 1999 Q1 | -6320.85 USD | 0.0% |
| 1999 Q3 | -4100.23 USD | 54.1% |
| 1999 Q2 | -8933.94 USD | -41.34% |
| 1998 FY | -6179.69 USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| American Bio Medica Corporation | -1.41 Million USD | -709.601% |
| Arrayit Corporation | -3.31 Million USD | -244.293% |
| Atlantic International Corp. | -5.62 Million USD | -102.847% |
| Biocept, Inc. | -32.08 Million USD | 64.424% |
| Bioqual, Inc. | 483.48 Thousand USD | 2461.08% |
| CardioGenics Holdings Inc | -1.91 Million USD | -495.691% |
| DermTech, Inc. | -100.88 Million USD | 88.685% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.02 Billion USD | 100.564% |
| HTG Molecular Diagnostics, Inc. | -21.59 Million USD | 47.138% |
| iMD Companies, Inc. | -200.63 Thousand USD | -5589.593% |
| IDenta Corp. | 14.64 Thousand USD | 78052.554% |
| Interpace Biosciences, Inc. | 802 Thousand USD | 1523.363% |
| Integrative Health Technologies, Inc. | 38.68 Thousand USD | 29605.472% |
| InVitro International | 1553.00 USD | 735152.93% |
| Lumos Diagnostics Holdings Limited | -8.59 Million USD | -32.86% |
| Many Bright Ideas Technologies Inc. | -58.11 Thousand USD | -19543.743% |
| Medical Imaging Corp. | -3.02 Million USD | -277.614% |
| NovelStem International Corp. | -4.18 Million USD | -172.619% |
| Optigenex Inc. | -2.89 Million USD | -293.938% |
| PharmChem, Inc. | 845.1 Thousand USD | 1450.769% |
| Proteome Sciences plc | -2.44 Million USD | -367.269% |
| Response Genetics, Inc | -20.18 Million USD | 43.443% |
| Rennova Health, Inc. | -3.29 Million USD | -246.65% |
| RushNet, Inc. | -607.02 Thousand USD | -1780.535% |
| ScreenPro Security Inc. | -2.24 Million USD | -407.628% |
| Stella Diagnostics Inc. | -5.7 Million USD | -100.009% |
| Todos Medical Ltd. | -24.99 Million USD | 54.328% |